COVID-19 Boosters Could Save 90,000 Lives This Winter
THURSDAY, Oct. 6, 2022 (HealthDay News) — The number Americans who will die of COVID-19 this winter could depend on how many get their booster shots, a new report shows.Up to 90,000 U.S. COVID-19 deaths could be prevented through the fall and winter,…
Learn MoreMove to Zero-Emission Trucks Could Save 66,000 U.S. Lives
THURSDAY, Oct. 6, 2022 (HealthDay News) — Replacing diesel-powered trucks with electric vehicles would save tens of thousands of U.S. lives, a new American Lung Association report says.The benefit would accrue if all medium- and heavy-duty trucks sol…
Learn MoreAI Can Identify Multisystem Inflammatory Syndrome in Children
THURSDAY, Oct. 6, 2022 (HealthDay News) — A deep-learning algorithm called KIDMATCH can distinguish between multisystem inflammatory syndrome in children (MIS-C), Kawasaki disease, and other similar febrile illnesses in children, according to a study…
Learn MoreResponse to Neoadjuvant Chemo for Breast Cancer Varies by Sex
THURSDAY, Oct. 6, 2022 (HealthDay News) — Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, according to…
Learn MoreAAO: One in Nine Patients With Wet AMD Skip Follow-Up
THURSDAY, Oct. 6, 2022 (HealthDay News) — One in nine people with wet age-related macular degeneration (AMD) are skipping appointments for sight-saving eye injections, according to a study presented at the annual meeting of the American Academy of Op…
Learn MoreHigh Framingham Risk Score Seen for Women With History of Migraine
THURSDAY, Oct. 6, 2022 (HealthDay News) — High Framingham risk score (FRS) categories are seen among women with a history of migraine, but not for those with active migraine at baseline or during follow-up, according to a study published online Aug. …
Learn MoreTreatment Sequence Studied for Advanced BRAF-Mutant Melanoma
THURSDAY, Oct. 6, 2022 (HealthDay News) — For patients with treatment-naive BRAFv600 mutant metastatic melanoma, treatment first with combination nivolumab/ipilimumab yields better overall survival than dual BRAF/MEK inhibition with dabrafenib/tramet…
Learn MoreAAP Addresses Safety for Children in Emergency Care Settings
THURSDAY, Oct. 6, 2022 (HealthDay News) — All emergency departments should understand the unique safety issues related to children, according to a policy statement and accompanying technical report released by the American Academy of Pediatrics, Amer…
Learn MoreEffects of Weight Loss Methods Examined by Baseline Body Weight
THURSDAY, Oct, 6, 2022 (HealthDay News) — The impact of weight loss strategies on weight change and diabetes risk may vary by baseline body weight, according to a study published online Sept. 27 in PLOS Medicine.Keyi Si, from the Harvard T. H. Chan S…
Learn MoreTreatments Compared for Pediatric-Onset Multiple Sclerosis
THURSDAY, Oct. 6, 2022 (HealthDay News) — More patients with pediatric-onset multiple sclerosis (POMS) are free of new or newly enlarging (N or NE) T2 hyperintense lesions with dimethyl fumarate (DMF) versus interferon β-1a (IFNβ-1a) treatment, and t…
Learn More